Background-The large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channel in the cardiac inner mitochondrial membrane (mitoK Ca channel) has been shown to protect the heart against ischemic injury. However, questions about the cardioprotective mechanism and the kinase-mediated regulation of mitoK Ca channels remain to be answered. 
A large amount of evidence has implicated mitochondrial ATP-sensitive K ϩ (mitoK ATP ) channels as a key element of cardioprotection. 1,2 A recent study by Xu et al 3 has revealed that, besides the mitoK ATP channels, largeconductance Ca 2ϩ -activated K ϩ (BK Ca ) channels are present on the mitochondrial inner membrane (mitoK Ca channels) of guinea pig ventricular myocytes. They have further demonstrated that pharmacological preconditioning of rabbit heart with the BK Ca channel opener NS1619 causes a significant reduction in infarct size, and such effect can be antagonized by the BK Ca channel blocker paxilline. 3 Despite these novel exciting observations, there are still many open questions about the nature of the mitoK Ca channels. First, it remains to be established whether the primary target for BK Ca channelselective agents 4, 5 in cardiac myocytes is the mitoK Ca channels, although sarcolemmal BK Ca channels have not been found in ventricular myocytes. 6 Second, the mechanism by which opening of mitoK Ca channels protects the heart against ischemic damage remains elusive. Third, although BK Ca channel in smooth muscle cells can be activated by cAMPdependent protein kinase (PKA), 7 the regulatory mechanism of cardiac mitoK Ca channels is unknown.
Therefore, the aim of the present study was to address these important questions. Flavoprotein oxidation has been used to determine the pharmacology and regulation of mitoK ATP channels in intact cardiac myocytes. 2, 8, 9 It is to be expected that K ϩ entry through mitoK Ca channels leads to net oxidation of the mitochondria in the same manner as mitoK ATP channels. To determine whether NS1619 and paxilline can selectively act on mitoK Ca channels, we examined the effects of these drugs on flavoprotein oxidation in guinea pig ventricular myocytes. It has been demonstrated that mitochondrial Ca 2ϩ accumulation is attenuated by mitoK ATP channel activation. 10 -12 To explore the mechanism of cardioprotection, we determined whether opening of mitoK Ca channels attenuates the mitochondrial Ca 2ϩ overload. A previous study has shown that, with the use of the flavoprotein fluorescence method, mitoK ATP channel activation is potentiated by protein kinase C (PKC). 9 In the present study we investigated the effects of PKA and PKC activators on mitoK Ca channel activity.
Methods

Cell Preparation
Adult guinea pig ventricular myocytes were isolated by collagenase digestion as previously described. 13 
Flavoprotein Fluorescence
The autofluorescence of mitochondrial flavoprotein was measured by a modification of method described by Sato et al. 9 Briefly, the cells were superfused with glucose-free Tyrode's solution containing the following (mmol/L): NaCl 140, KCl 5. 
Mitochondrial Ca 2؉ Concentration and Membrane Potential Measurements
The mitochondrial Ca 2ϩ concentration ([Ca 2ϩ ] m ) was measured by loading cells with the Ca 2ϩ fluorophore rhod-2. Myocytes were loaded with 10 mol/L rhod-2 acetoxymethyl ester for 120 minutes at 4°C and then incubated for 30 minutes at 37°C in the culture medium. This 2-step cold loading/warm incubation protocol achieves exclusive loading of rhod-2 into the mitochondria. 14 The mitochondrial membrane potential (⌬⌿ m ) was monitored with the fluorescent probe JC-1. Myocytes were incubated with 0.5 mol/L JC-1 for 10 minutes at 37°C. 15 Myocytes loaded with rhod-2 or JC-1 were perfused with normal Tyrode's solution (37°C) containing the following (mmol/L): NaCl 140, KCl 5.4, CaCl 2 2.7, NaH 2 PO 4 0.33, MgCl 2 0.5, HEPES 5, and glucose 5.5 (pH 7.4). Rhod-2 fluorescence was excited at 540 nm, with emission monitored through a 605-nm (55-nm bandpass) barrier filter. JC-1 was excited at 488 nm, and the red emission fluorescence was detected with the use of a long-pass filter of 580 nm.
Cytosolic Ca 2؉ Concentration Measurement
The cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] c ) was measured by loading cells with fluo-3. Myocytes were incubated in a 1-mol/L fluo-3 acetoxymethyl ester-containing loading solution at 37°C in the dark for 30 minutes, as previously described. 16 The loading solution was prepared by diluting a 10-mol/L fluo-3 stock solution, which contained 0.45% Pluronic F127, 10% dimethyl sulfoxide, and 90% FBS. Myocytes loaded with fluo-3 were perfused with normal Tyrode's solution (37°C), and fluo-3 fluorescence was excited at 480 nm and emitted at 520 nm.
Fluorescence Imaging
Emitted fluorescence was monitored with a cooled charge-coupled device digital camera (C4742-95, Hamamatsu Photonics). The imaging of flavoprotein, rhod-2, JC-1, and fluo-3 fluorescence was analyzed for average pixel intensities of regions of interest drawn to include whole cells, after correction for background, with the use of an Aquacosmos image-processing system (Hamamatsu Photonics).
Cell Viability
In another series of experiments, cells were exposed to ouabain without loading fluorescent dyes, and cell viability was determined by trypan blue exclusion assay. After 40-minute exposure to ouabain (1 mmol/L), 20 L of 0.4% trypan blue was added into the recording chamber, and cells permeable to trypan blue were counted and expressed as a percentage of the total viable cells before application of drugs.
Chemicals
NS1619, paxilline, diazoxide, 5-hydroxydecanoate (5HD), ouabain, forskolin, 8-bromoadenosine 3Ј5Ј-cyclic monophosphate (8Br-cAMP), and phorbol 12-myristate 13-acetate (PMA) were purchased from Sigma. Rhod-2 acetoxymethyl ester, JC-1, fluo-3 acetoxymethyl ester, and Pluronic F127 were purchased from Molecular Probes. DNP was purchased from Wako Pure Chemicals. NS1619, paxilline, diazoxide, forskolin, 8Br-cAMP, and PMA were dissolved in dimethyl sulfoxide before they were added to the experimental solution, and final concentration of solvent was Յ0.1%. Ouabain, 5HD, and DNP were dissolved in the perfusate.
Statistical Analysis
Data are expressed as meanϮSEM, and the number of cells or experiments is shown as n. Statistical comparisons were made with the use of Student t test or ANOVA combined with Fisher post hoc test, as appropriate. A value of PϽ0.05 was regarded as significant.
Results
Figure 1A through 1C shows representative time course of changes in flavoprotein fluorescence in a cell exposed to NS1619 and/or paxilline. NS1619 (30 mol/L) reversibly oxidized flavoproteins, and subsequent exposure to DNP (100 mol/L) led to full oxidation of flavoproteins ( Figure 1A ). In the presence of paxilline (2 mol/L), NS1619 failed to oxidize flavoproteins ( Figure 1B) . Furthermore, the NS1619-induced flavoprotein oxidation was suppressed by subsequent application of paxilline ( Figure 1C ). Figure 1D shows that NS1619 oxidized flavoproteins even in the presence of the mitoK ATP channel blocker 5HD (500 mol/L). On the other hand, as shown in Figure 1E , paxilline did not inhibit the flavoprotein oxidation induced by the mitoK ATP channel opener diazoxide (100 mol/L). Figure 1F further shows that oxidative effects of NS1619 and diazoxide were additive: diazoxide (30 mol/L) augmented the flavoprotein oxidation when applied after the effect of NS1619 (10 mol/L) had reached steady state. As summarized in Figure 1G , NS1619 (3 to 100 mol/L) oxidized flavoproteins in a concentrationdependent manner. Paxilline completely inhibited the oxidative effects of NS1619 (30 mol/L) from 25Ϯ3% to 4Ϯ1% of the DNP value (PϽ0.0001). 5HD (500 mol/L) did not affect the oxidative effect of 30 mol/L NS1619 (27Ϯ3%; PϭNS versus NS1619 alone). In addition, diazoxide (100 mol/L) increased flavoprotein oxidation (32Ϯ4%) even in the presence of paxilline, and this degree of oxidation was comparable to that obtained by applying diazoxide alone (33Ϯ3%). The combined application of NS1619 (10 mol/L) and diazoxide (30 mol/L) had an additive effect and significantly increased flavoprotein oxidation to 41Ϯ7% (PϽ0.05) compared with NS1619 (16Ϯ2%) or diazoxide (21Ϯ3%) alone. These results suggest that NS1619 activates whereas paxilline inhibits the mitoK Ca channels, independently of the mitoK ATP channels.
We then examined whether opening of mitoK Ca channels by NS1619 attenuates the mitochondrial Ca 2ϩ overload. As summarized in Figure 2A , exposing cells to ouabain exposure to ouabain (25Ϯ2%; PϽ0.05). The cardioprotective effect of NS1619 was abolished by 2 mol/L paxilline (44Ϯ4%; PϽ0.05 versus ouabain plus NS1619).
To study the protein kinase-dependent modulation of mitoK Ca channels, we examined the effects of activators of PKA and PKC on flavoprotein oxidation. Figure 4A shows a representative effect of the cell-permeable cAMP analogue 8Br-cAMP on NS1619-induced flavoprotein oxidation. 8Br-cAMP (0.5 mmol/L) enhanced the oxidative effect of NS1619 (30 mol/L) when applied after the effect of NS1619 had reached steady state. Although 8Br-cAMP alone had no significant effect on flavoprotein fluorescence (Figure 4E ), the drug significantly increased the NS1619-induced flavoprotein oxidation (NS1619 of 23Ϯ4% versus NS1619 plus 8Br-cAMP of 41Ϯ7%; PϽ0.05; Figure 4B ). Figure 4E further shows that forskolin, a direct activator of adenylate cylcase, 17 mimicked the potentiating effect of 8Br-cAMP, and exposure to 10 mol/L forskolin significantly increased NS1619-induced flavoprotein oxidation from 24Ϯ4% to 38Ϯ5% (PϽ0.05). In contrast, as shown in Figure 4C and 4D, PKC-activating phorbol ester PMA (100 nmol/L) did not alter the oxidative effect of NS1619 (NS1619 of 22Ϯ5% versus NS1619 plus PMA of 21Ϯ4%; PϭNS). Furthermore, 8Br-cAMP did not augment the flavoprotein oxidation induced by the mitoK ATP channel opener diazoxide (100 mol/L) (diazoxide of 34Ϯ6% versus diazoxide plus 8Br-cAMP of 31Ϯ6%; PϭNS). These results indicate that mitoK Ca channels are modulated by PKA but not by PKC.
Discussion
The existence of mitoK Ca channels has been found in a patch-clamp study performed on mitoplasts prepared from cardiac myocytes, 3 although proteomic analysis of mitochondrial inner membrane did not allow identification of mitoK Ca channels. 18 A role for mitoK Ca channel in K ϩ transport into the matrix has been proposed, and such K ϩ influx can be augmented by the BK Ca channel opener NS1619. 3 We therefore reasoned that, in a manner similar to that for the mitoK ATP channel, K ϩ influx through mitoK Ca channels accelerates electron transfer by the respiratory chain and leads to net oxidation of mitochondria if uncompensated by electron donors. 2, 8 As expected, the BK Ca channel opener NS1619 reversibly oxidized flavoproteins in a concentrationdependent manner; this effect was antagonized by the BK Ca channel blocker paxilline. The specificity of NS1619 and paxilline for mitoK Ca channel is further supported by the following results. The oxidative effect of NS1619 was unaffected by the mitoK ATP channel blocker 5HD, consistent with previous study in patch-clamping mitoplasts. 2 Paxilline failed to inhibit the flavoprotein oxidation induced by the mitoK ATP channel opener diazoxide. Taken together, these results indicate that NS1619 activates whereas paxilline inhibits the mitoK Ca channels, without affecting cardiac mitoK ATP channels.
Previous studies failed to demonstrate the oxidation of flavoproteins by diazoxide, presumably because measure- ments of flavoprotein fluorescence were performed in the presence of glucose with the use of freshly isolated cardiomyocytes. 19, 20 In our experiments, cells were kept in culture medium to stabilize the mitochondrial redox state. Moreover, to minimize the production of electron donors and thereby amplify the small signal due to opening of mitoK Ca and/or mitoK ATP channels, 1,2 cells were perfused with glucose-free Tyrode's solution. Consequently, we have succeeded in detecting flavoprotein oxidation induced not only by diazoxide but also by NS1619. Notably, we found that oxidation of flavoproteins by both NS1619 and diazoxide was additive. These results suggest that mitochondrial oxidation induced by opening of mitoK Ca and mitoK ATP channels occurs independently of each other and further indicate that the flavoprotein fluorescence is a useful index to assay not only mitoK ATP but also mitoK Ca channel activity in intact cardiomyocytes.
Ishida et al 11, 21 previously reported that opening of mitoK ATP channels by diazoxide and nicorandil depolarizes the ⌬⌿ m and attenuates the mitochondrial Ca 2ϩ overload during application of ouabain. Using the same experimental design, in the present study we examined the effect of NS1619, a potent mitoK Ca channel opener, on the ouabain-induced mitochondrial Ca 2ϩ overload. Elevation of [Ca 2ϩ ] c occurs during application of ouabain, as evidenced by increased fluo-3 fluorescence and which eventually results in the mitochondrial Ca 2ϩ overload. NS1619 attenuated the mitochondrial Ca 2ϩ overload, and the increase in rhod-2 fluorescence was blunted, without significant changes in fluo-3 fluorescence. This effect of NS1619 was antagonized by the mitoK Ca channel blocker paxilline. The independence of mitoK ATP channels was confirmed by ensuring that the effect of NS1619 was unaffected by 5HD, and paxilline failed to prevent the effect of diazoxide. Furthermore, we found that NS1619 produced a small reduction of ⌬⌿ m that was blocked by paxilline. Because Ca 2ϩ uptake into mitochondria is driven primarily by the ⌬⌿ m , 22 23 It is therefore reasonable to assume that such an effect of mitoK Ca channel can be attributed to the mechanism of cardioprotection. Although we used ouabain in an attempt to produce mitochondrial Ca 2ϩ overload experimentally, the mode of the ouabain-induced cell death by either necrosis or apoptosis remains to be determined. It has been reported that mitoK ATP channel opening prevents apoptosis, presumably by inhibiting the activation of the mitochondrial permeability transition pore. 24 Further investigations are required to demonstrate whether mitoK Ca channel opening exerts its protective effect by inhibiting both necrosis and apoptosis, as is the case with the mitoK ATP channel.
Modulation of the mitoK ATP channel by PKC was revealed by a previous study that showed that PKC-activating phorbol ester PMA potentiates the mitochondrial oxidation induced by diazoxide in rabbit ventricular myocytes. 9 Moreover, potentiation of mitoK ATP channel activation by adenosine via a PKC-mediated pathway was demonstrated with the same method. 25 In the present study mitoK Ca channel activity was indexed by measuring flavoprotein oxidation, and we found that 8Br-cAMP, but not PMA, potentiated the NS1619-induced flavoprotein oxidation. This potentiation could not be due to nonspecific action of 8Br-cAMP because 8Br-cAMP alone did not increase flavoprotein oxidation, nor did treatment with 8Br-cAMP enhance the diazoxide-induced oxidation. Furthermore, the NS1619-induced flavoprotein oxidation was similarly potentiated by another PKA activator, forskolin. Therefore, these findings suggest that the mitoK Ca channel is modulated by PKA, as is the case for the BK Ca channel in smooth muscle. 7 We found that 8Br-cAMP did not significantly increase the intensity of rhod-2 fluorescence (105Ϯ4% of baseline; nϭ8; not shown). Although further study is needed to know how PKA interacts with the mitoK Ca channel, it seems unlikely that the enhanced response of NS1619 could be secondary to the elevation of [Ca 2ϩ ] m . Xu et al 3 demonstrated that pharmacological preconditioning of rabbit heart with the BK Ca channel opener NS1619 significantly reduces infarct size, and such effect can be antagonized by the BK Ca channel blocker paxilline. However, the mechanism by which preconditioning with NS1619 results in infarct size reduction remains poorly understood. Our findings may provide insight into a mechanism responsible for mitoK Ca channel-mediated cardioprotection, ie, mitoK Ca activation blunts mitochondrial Ca 2ϩ accumulation during ischemia. Interestingly, ischemic preconditioning increases myocardial cAMP level and activates PKA in rat hearts, 26 but a role of PKA in the process of ischemic preconditioning is as yet incompletely understood. Our present results further suggest that mitoK Ca channel activity can be augmented by PKA and thus may provide a mechanistic link between the signal transduction of PKA-dependent preconditioning and its likely effector.
In conclusion, our data indicate that (1) NS1619 and paxilline target cardiac mitoK Ca channels, (2) opening of mitoK Ca channels attenuates mitochondrial Ca 2ϩ overload Figure 5 . overload.
